AGENDA

Friday, October 16, 2020

12:00 – 12:50 PM

Lunch

12:50 – 1:00 PM

Welcome/Introduction

SESSION I (TBD)

1:00 – 1:30 PM

Hepatitis C: Expanding Indications, Black Box Warnings and Screening

Vinod Rustgi, MD

1:30 – 2:00 PM

NAFLD/NASH: Screening, Current Management and Treatments on the Horizon

David Bernstein, MD

2:00 – 2:55 PM

Complications of Portal Hypertension: Management Options for Hepatic Encephalopathy, Thrombocytopenia, Varices, and Hepatorenal Syndrome

Kimberly Brown, MD and Robert Brown, MD

2:55 – 3:15 PM

Q&A / Panel Discussion

3:15 – 3:30 PM

Break

SESSION II (William Chey, MD)

3:30 – 3:55 PM

Common Dilemmas in the Diagnosis and Management of Drug-Induced Liver Injury 

Ira Jacobson, MD

3:55 – 4:25 PM

Management of Fecal Incontinence 

Baha Moshiree, MD 

4:25 – 4:50 PM

Microbiome-Based Treatments for IBS: Food, Bugs or Drugs

William Chey, MD

4:50 – 5:15 PM

Q&A / Panel Discussion

5:15 – 5:30 PM

Day 1 Wrap-up

5:30 – 7:00 PM

Welcome Reception

Saturday, October 17, 2020

7:30 – 8:20 AM

Breakfast

8:20 – 8:30 AM

Welcome

SESSION III (Michael Vaezi, MD)

8:30 – 9:00 AM

How Opioid Use Might Impact Esophageal Symptoms and Motility 

Michael Vaezi, MD

9:00 – 9:30 AM

GERD and Sleep: An Eye-opening Experience

Ronnie Fass, MD

9:30 – 10:00 AM

Chronic Pancreatitis

Allison Yang, MD

10:00 – 10:30 AM

Q&A / Panel Discussion

10:30 – 10:45 AM

Break

10:45 – 11:45 AM

Parallel Sessions

(Attendees select one of the following)

  • Inflammatory Bowel Disease 

  • GI Woes from Head to Toe 

  • Viral Hepatitis, Cholestatic Disease and Complications of Cirrhosis

  • Alcoholic and Nonalcoholic Fatty Liver Disease

12:00 PM – 1:00 PM

Lunch

SESSION IV (Stephen Hanauer, MD)

1:00 – 1:25 PM

Selecting Therapy Based on Prognosis in Ulcerative Colitis and Crohn’s Disease

Gary Lichtenstein, MD

1:25 – 1:50 PM

Practical Applications of Treat to Target in Inflammatory Bowel Disease (IBD)

Stephen Hanauer, MD

1:50 – 2:15 PM

Managing Post-operative Crohn’s Disease

David Binion, MD

2:15 – 2:40 PM

Applying Dietary Interventions in Inflammatory Bowel Disease (IBD)

(TBD)

2:40 – 3:05 PM

Q&A / Panel Discussion

3:05 – 3:20 PM

Break

SESSION V (Nikolaos Pyrsopoulos, MD)

3:20 – 3:50 PM

Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC): Diagnosis and Treatment

Nikolaos Pyrsopoulos, MD

3:50 – 4:20 PM

Hepatocellular Carcinoma: Diagnosis and Treatment

Hashem El-Serag, MD

4:20 – 4:40 PM

Q&A/Panel Discussion

4:40 – 4:45 PM

Meeting Wrap-up

  • Facebook Social Icon
  • Twitter Social Icon

This activity is supported by educational grants from AbbVie, Allergan Inc., Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

TLI.png

© 2020 GI and Liver Association of the Americas